SavithaSubramanianMD

Endocrinology • Seattle, WA

Diabetes, Lipid Metabolism

Professor, Medicine, University of Washington School of Medicine

Join to view full profile

Dr. Subramanian is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Subramanian's full profile

Already have an account?

Office
750 Republican Street 3rd flr
Building F
Seattle, WA 98109
Phone+1 206-598-4882

Education & Training

University of WashingtonFellowship, Endocrinology, Diabetes, and Metabolism, 2004 - 2005
Washington University/B-JH/SLCH ConsortiumFellowship, Endocrinology, Diabetes, and Metabolism, 2002 - 2004
Carle Foundation HospitalResidency, Internal Medicine, 1999 - 2002
Stanley Medical College SMCClass of 1997

Certifications & Licensure

WA State Medical License 2004 - 2025
IL State Medical License 1999 - 2002
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

A Study to Examine the Effects of the Leptin Receptor (LEPR) Agonist Antibody REGN4461 in Adult Patients With Familial Partial Lipodystrophy (FPLD) Start of enrollment: 2022 Feb 28
Terminated
Phase 2
Roles: Principal Investigator, Contact

Publications & Presentations

PubMed

Incretin-Based Therapies and Lifestyle Interventions: The Evolving Role of Registered Dietitian Nutritionists in Obesity Care.
Linda Gigliotti, Hope Warshaw, Alison Evert, Colleen Dawkins, Julie Schwartz
Journal of the Academy of Nutrition and Dietetics. 2024-11-07
1 citations
Therapy for Hyperlipidemia.
Jennifer Wright, Savitha Subramanian
The Medical Clinics of North America. 2024-09-01
6 citations
New advances in type 1 diabetes.
Savitha Subramanian, Farah Khan, Irl B Hirsch
BMJ. 2024-01-26

Books/Book Chapters

Endotext
Chapter: Hypertriglyceridemia: Pathophysiology, Role of Genetics, Consequences, and Treatment.
Alan Chait and Savitha Subramanian

Lectures

Meeting the Needs of Patients, Not LDL-C Goals: The Role of PCSK9 Inhibitor
ENDO 2019 - New Orleans, LA - 3/25/2019
ESAP Live
ENDO 2019 - New Orleans, LA - 3/24/2019

Press Mentions

Do Statins Increase the Risk of Diabetes?October 25th, 2022

Professional Memberships

Endocrine Society
Member
American Diabetes Association - ADA
Member
National Lipid Association
Member